MSB 3.13% 99.0¢ mesoblast limited

Cell Therapy News/Articles, page-17034

  1. 30,340 Posts.
    lightbulb Created with Sketch. 1837
    Potency assays. It's not about potency per se. The FDA is recently obsessed with tracking and evaluating the precise operation of the therapy.
    It's odd that they are doing this, since they normally don't bother.
    Indeed, many drugs and therapies get approved on the basis of correlation, the precise operation of them is not understood and nobody worries.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
99.0¢
Change
0.030(3.13%)
Mkt cap ! $1.130B
Open High Low Value Volume
96.5¢ $1.03 96.5¢ $4.704M 4.708M

Buyers (Bids)

No. Vol. Price($)
6 87395 98.5¢
 

Sellers (Offers)

Price($) Vol. No.
$1.00 274051 2
View Market Depth
Last trade - 16.10pm 14/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.